Prof. Dr. Haochen Yao | Nanotechnology | Best Researcher Award
Dr. Haochen Yao is an accomplished Associate Professor affiliated with the Key Laboratory & Engineering Laboratory of Lymphatic Surgery of Jilin Province and the China-Japan Union Hospital at Jilin University. With a deep-rooted dedication to clinical innovation and translational research in lymphatic and vascular diseases, Dr. Yao has made significant contributions to biomedical science, particularly in immune modulation and nanomedicine. His career reflects a balance of academic excellence, clinical practice, and impactful scientific discovery.
Professional profileš¤
Strengths for the AwardsāØ
-
High-Impact Publications:
Dr. Yao has an impressive publication record in top-tier journals such as Nano Letters, Advanced Science, ACS Applied Materials & Interfaces, and Biomaterials. Many of these journals have high impact factors (ranging from 6.2 to 14.3), indicating the significance and quality of his work. -
Cutting-Edge Research Areas:
His research focuses on cancer immunotherapy, nanomedicine, biomaterials, and tumor microenvironment modulationāfields that are both clinically relevant and technologically advanced. These areas have significant translational potential, especially for oncology and regenerative medicine. -
Innovative Techniques:
Dr. Yao utilizes advanced methodologies, including nano-drug delivery, immune checkpoint enhancement, and hydrogel-based wound healing, showcasing technical innovation. -
Multidisciplinary Collaboration:
His affiliations with engineering laboratories and joint research centers demonstrate strong interdisciplinary collaboration, essential for translational biomedical research. -
Leadership and Recognition:
As an associate professor and corresponding or first author on several papers, Dr. Yao has shown leadership in his research teams. He also works in recognized institutions like Jilin University and the Chinese Academy of Sciences.
š Education
Dr. Yao earned all his academic degrees from Jilin University, reflecting a profound and continuous commitment to medical science. He completed his Ph.D. in Pathogenic Biology (2019ā2022), preceded by a Masterās degree in Surgery (2015ā2018), and a Bachelorās degree in Clinical Medicine (2009ā2014). This progressive academic pathway underscores his solid foundation in both theoretical knowledge and clinical skills.
š¼ Experience
Currently serving as an Attending Physician at the General Surgery Center of the First Hospital of Jilin University (2022.09ā2025.03), Dr. Yao combines medical practice with cutting-edge research. He previously contributed as a Research Assistant at the Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences (2019.09ā2022.06), where he cultivated his expertise in polymeric biomaterials and nano-based therapeutic systems.
š¬ Research Interest On Nanotechnology
Dr. Yaoās research interests span nanomedicine, tumor immunotherapy, lymphatic system diseases, and biomaterials. His work is particularly focused on enhancing immune checkpoint therapies, modulating gut microbiota for cancer treatment, and designing multifunctional nanoprodrugs. He is passionate about integrating materials science with clinical oncology to develop next-generation therapeutics.
š Awards
While specific awards are not listed in the provided CV, Dr. Yao’s consistent authorship in high-impact journals and his progressive academic and professional roles indicate recognition and respect in his field. This nomination itself stands as a testament to his outstanding contributions and potential.
š Publications
Dr. Yao has authored numerous impactful publications in leading journals. Below is a selection of his peer-reviewed work:
1. A Syringeable Immunotherapeutic Hydrogel Enhances T Cell Immunity via In-Situ Activation of STING Pathway for Advanced Breast Cancer Postoperative Therapy
-
Authors: Baozhen Zhang, Min Li, Jiahua Ji, Xinghui Si, Xiaojiao Yin, Guofeng Ji, Liqun Ren, Haochen Yao
-
Year: 2025
-
Journal: Frontiers in Immunology
2. An Antibacterial Hemostasis Sponge of Gelatin/ε-Poly-L-Lysine Composite
-
Authors: Yifan Lu, Xiangxin Lou, Wenxin Wang, Ziting Yang, Haochen Yao, Jinglei Wu
-
Year: 2025
-
Journal: Journal of Biomedical Materials Research Part B: Applied Biomaterials
-
DOI: 10.1002/jbm.b.35528
3. Chitosan-Based Immunomodulatory Bioadhesive Hydrogel Promotes Liver Hemostasis and Repair
-
Authors: Wenxin Wang, Haochen Yao, Jie Xia, Xinjian Wan, Jinglei Wu
-
Year: 2025
-
Journal: Carbohydrate Polymers
4. In-Situ Activation of Biomimetic Single-Site Bioorthogonal Nanozyme for Tumor-Specific Combination Therapy
-
Authors: Mengmeng Ma, Wei Yuan, Wenbin Zhong, Yu Cheng, Haochen Yao, Yanli Zhao
-
Year: 2025
-
Journal: Biomaterials
5. Synergistic Design of Hierarchical and Heterostructural P-NiMoOā@Net-like NiāP for Enhanced Hydrogen Evolution Electrocatalysis
-
Authors: Jian Tang, Jun Fang, Haochen Yao, Jianglong Wei, Geng Gao, Yusong Yang, Bin Yang, Yaochun Yao
-
Year: 2025
-
Journal: Journal of Colloid and Interface Science
6. HighāEfficiency Carriersā Separation Strategy Based UltrasmallāBandgap CuWOā SonoāEnhances GSH Antagonism for Cuproptosis Cascade Immunotherapy
-
Authors: Lichao Zhu, Zhisheng Guo, Yu Luo, Haiyan Huang, Kexin Zhang, Bingbing Duan, Renmiao Peng, Haochen Yao, Chao Liang, Kaiyang Wang
-
Year: 2025
-
Journal: Advanced Science
7. MyocardiaāInjected Synergistically AntiāApoptotic and AntiāInflammatory Poly(amino acid) Hydrogel Relieves IschemiaāReperfusion Injury
-
Authors: Qiang Luo, Zhibo Li, Wei Sun, Guoliang Wang, Haochen Yao, Guoqing Wang, Bin Liu, Jianxun Ding
-
Year: 2025
-
Journal: Advanced Materials
8. A Tumor-Targeting Nano-Adjuvant for In Situ Vaccine Based on Ultrasound Therapy
-
Authors: Linjie Cui, Haochen Yao, Fuxin Xue, Jiali Sun, Xitong Ren, Mengfei Zheng, Zhilin Liu, Zhaohui Tang
-
Year: 2024
-
Journal: Aggregate
-
DOI: 10.1002/agt2.504
š Conclusion
Dr. Haochen Yao represents the future of translational biomedical research. His multidisciplinary approach, spanning surgery, nanotechnology, and immunology, exemplifies innovation with clinical relevance. His trajectory from clinical medicine to high-impact scientific contribution makes him a compelling candidate for this award nomination. š